We are a start-up in Biotechnology consultancy services for infectious diseases and genetic disorders. For entry into to medical biotech domain, and as Pandemic Novel SARS Coronavirus 2 (COVID19) comes in, we are providing specialized services on COVID19: under B2B services. Clinical Trials, Diagnostics, Therapeutics, Product Development